C12N 9/6464
Protein c
Official title: {Protein C (3.4.21.69)}
C12N9/6464 (Protein c) appears on 130 US grants and 62 published applications in this corpus.
Search patents in C12N- Granted patents
- 130
- Published applications
- 62
- Assignees
- 62
- Inventors
- 210
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 5 | 0 |
| 1993 | 6 | 0 |
| 1994 | 7 | 0 |
| 1995 | 5 | 0 |
| 1996 | 11 | 0 |
| 1997 | 7 | 0 |
| 1998 | 13 | 0 |
| 1999 | 9 | 0 |
| 2000 | 10 | 0 |
| 2001 | 5 | 2 |
| 2002 | 8 | 3 |
| 2003 | 3 | 9 |
| 2004 | 4 | 6 |
| 2005 | 2 | 6 |
| 2006 | 2 | 2 |
| 2007 | 4 | 1 |
| 2008 | 0 | 2 |
| 2009 | 2 | 1 |
| 2010 | 3 | 4 |
| 2011 | 0 | 5 |
| 2012 | 2 | 3 |
| 2013 | 2 | 4 |
| 2014 | 4 | 2 |
| 2015 | 1 | 2 |
| 2016 | 2 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 3 |
| 2022 | 0 | 0 |
| 2023 | 2 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 2 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance26 May 2026US 12,637,690 B2eGenesis, Inc.
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance19 May 2026US 12,630,838 B2eGenesis, Inc.
- Protein C zymogen and methods of use thereof to prevent cancer metastases20 Jan 2026US 12,527,848 B2The Children’s Hospital of Philadelphia
- Peptides that inhibit binding of EPCR to its ligand to treat inflammation21 Nov 2023US 11,820,833 B2Tel HaShomer Medical Research Infrastructure and Services Ltd.
- Protein C-factor VII chimeras24 Jan 2023US 11,560,556 B2Duke University
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance9 Apr 2026US 2026/0098278 A1eGenesis, Inc.
- Processing and fabrication of composite silk-based plastics8 Jan 2026US 2026/0009013 A1
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance13 Nov 2025US 2025/0346918 A1eGenesis, Inc.
- Sequence of activated protein c5 Jun 2025US 2025/0177571 A1Jichi Medical University
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance14 Mar 2024US 2024/0084322 A1eGenesis, Inc.
Most cited
By later US patents
- Transgenic bovine266US 5,741,957 APharming B.V. · 1998
- Vectors and compounds for expression of human protein C88US 4,775,624 AEli Lilly and Company · 1988
- Modified vitamin K-dependent polypeptides62US 6,017,882 ARegents of the University of Minnesota · 2000
- Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders57US 6,818,439 B1Chiron Corporation · 2004
- Monoclonal antibody specific for protein C and antibody purification method52US 5,202,253 AOklahoma Medical Research Foundation · 1993